The expression patterns of PD-L1 and PD-L2 vary across tumor types [189], and their interaction with PD-1 on tumor-infiltrating lymphocytes (TILs) is suggested as a mechanism of tumor immune escape. The gene discussed is PDCD1; the disease is neoplasm.